Progress Toward Polio Eradication January 2017-March 2019 Progress Toward Polio Eradication January 2017-March 2019
This report provides the most recent data on the global fight to eradicate polio. Are we making progress?Morbidity &Mortality Weekly Report
Conclusions: We employed a closed-population study to generate AFM incidence, risk and outcome data. Our findings support previous reports of male sex and atopy as risk factors. Interval increase in incidence, predisposing Asian ancestry and history of head injury were unique findings to this study. Overall prognosis was better than prior reports, but recovery was incomplete in several patients.
Olivia Hanson, seven, from Grand Rapids, Michigan, was diagnosed with acute flaccid myelitis in September 2018 after she came down with a sore throat and a high fever.
(PLOS) Discovery of a new feature of a large class of pathogenic viruses may allow development of new antiviral medications for the common cold, polio, and other illnesses, according to a new study publishing June 11, 2019 in the open-access journal PLOS Biology by Rana Abdelnabi and Johan Neyts of the University of Leuven, Belgium, and James Geraets and Sarah Butcher of the University of Helsinki and their colleagues.
[Dalsan Radio] Somalia will kick off a countrywide polio campaign of two rounds of immunisation to deliver monovalent oral vaccine type 2.
[East African] Somalia will kick off a countrywide polio campaign of two rounds of immunisation to deliver monovalent oral vaccine type 2.
[Radio Dabanga] Khartoum -The UN Office for the Coordination of Humanitarian Affairs (OCHA) in Sudan reports in its latest bulletin that a large-scale measles and polio vaccination campaign has so far reached 9.1 million children in Sudan. In Jebel Marra in Darfur, more than 2,600 people fled their homes following fighting between two rebel factions in February. A number of aid organizations and the UN-AU Mission in Darfur (Unamid) have been plundered. Food insecurity in Sudan continues, despite a good harvest.
[Guardian] The World Health Organisation (WHO) has alerted to a recent emergence and spread of new strains of vaccine-derived poliovirus type 2 (cVDPV2) in southern Nigeria and, especially Lagos.
On 23 May 2019, WHO received notification through the Global Polio Laboratory Network (GPLN) of the detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) from an environmental sample collected on 20 April 2019 in a hospital in Northern Cameroon which borders Borno state in Nigeria and Chad.
This study is registered with EudraCT, number 2017-000908-21 and ClinicalTrials.gov, number NCT03430349.FindingsBetween May 22 and Aug 22, 2017, 48 volunteers were screened, of whom 15 (31%) volunteers were excluded for reasons relating to the inclusion or exclusion criteria, three (6%) volunteers were not treated because of restrictions to the number of participants in each group, and 30 (63%) volunteers were sequentially allocated to groups (15 participants per group). Both novel OPV2 candidates were immunogenic and increased the median blood titre of serum neutralising antibodies; all participants were seroprotected aft...
Publication date: Available online 4 June 2019Source: The LancetAuthor(s): Kimberly M Thompson